Cargando…

FTD/ALS Type 7-Associated Thr104Asn Mutation of CHMP2B Blunts Neuronal Process Elongation, and Is Recovered by Knockdown of Arf4, the Golgi Stress Regulator

Frontotemporal dementia and/or amyotrophic lateral sclerosis type 7 (FTD/ALS7) is an autosomal dominant neurodegenerative disorder characterized by the onset of FTD and/or ALS, mainly in adulthood. Patients with some types of mutations, including the Thr104Asn (T104N) mutation of charged multivesicu...

Descripción completa

Detalles Bibliográficos
Autores principales: Shirai, Remina, Cho, Mizuka, Isogai, Mikinori, Fukatsu, Shoya, Okabe, Miyu, Okawa, Maho, Miyamoto, Yuki, Torii, Tomohiro, Yamauchi, Junji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443297/
https://www.ncbi.nlm.nih.gov/pubmed/37606396
http://dx.doi.org/10.3390/neurolint15030063
_version_ 1785093796291149824
author Shirai, Remina
Cho, Mizuka
Isogai, Mikinori
Fukatsu, Shoya
Okabe, Miyu
Okawa, Maho
Miyamoto, Yuki
Torii, Tomohiro
Yamauchi, Junji
author_facet Shirai, Remina
Cho, Mizuka
Isogai, Mikinori
Fukatsu, Shoya
Okabe, Miyu
Okawa, Maho
Miyamoto, Yuki
Torii, Tomohiro
Yamauchi, Junji
author_sort Shirai, Remina
collection PubMed
description Frontotemporal dementia and/or amyotrophic lateral sclerosis type 7 (FTD/ALS7) is an autosomal dominant neurodegenerative disorder characterized by the onset of FTD and/or ALS, mainly in adulthood. Patients with some types of mutations, including the Thr104Asn (T104N) mutation of charged multivesicular body protein 2B (CHMP2B), have predominantly ALS phenotypes, whereas patients with other mutations have predominantly FTD phenotypes. A few mutations result in patients having both phenotypes approximately equally; however, the reason why phenotypes differ depending on the position of the mutation is unknown. CHMP2B comprises one part of the endosomal sorting complexes required for transport (ESCRT), specifically ESCRT-III, in the cytoplasm. We describe here, for the first time, that CHMP2B with the T104N mutation inhibits neuronal process elongation in the N1E-115 cell line, a model line undergoing neuronal differentiation. This inhibitory phenotype was accompanied by changes in marker protein expression. Of note, CHMP2B with the T104N mutation, but not the wild-type form, was preferentially accumulated in the Golgi body. Of the four major Golgi stress signaling pathways currently known, the pathway through Arf4, the small GTPase, was specifically upregulated in cells expressing CHMP2B with the T104N mutation. Conversely, knockdown of Arf4 with the cognate small interfering (si)RNA recovered the neuronal process elongation inhibited by the T104N mutation. These results suggest that the T104N mutation of CHMP2B inhibits morphological differentiation by triggering Golgi stress signaling, revealing a possible therapeutic molecular target for recovering potential molecular and cellular phenotypes underlying FTD/ALS7.
format Online
Article
Text
id pubmed-10443297
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104432972023-08-23 FTD/ALS Type 7-Associated Thr104Asn Mutation of CHMP2B Blunts Neuronal Process Elongation, and Is Recovered by Knockdown of Arf4, the Golgi Stress Regulator Shirai, Remina Cho, Mizuka Isogai, Mikinori Fukatsu, Shoya Okabe, Miyu Okawa, Maho Miyamoto, Yuki Torii, Tomohiro Yamauchi, Junji Neurol Int Article Frontotemporal dementia and/or amyotrophic lateral sclerosis type 7 (FTD/ALS7) is an autosomal dominant neurodegenerative disorder characterized by the onset of FTD and/or ALS, mainly in adulthood. Patients with some types of mutations, including the Thr104Asn (T104N) mutation of charged multivesicular body protein 2B (CHMP2B), have predominantly ALS phenotypes, whereas patients with other mutations have predominantly FTD phenotypes. A few mutations result in patients having both phenotypes approximately equally; however, the reason why phenotypes differ depending on the position of the mutation is unknown. CHMP2B comprises one part of the endosomal sorting complexes required for transport (ESCRT), specifically ESCRT-III, in the cytoplasm. We describe here, for the first time, that CHMP2B with the T104N mutation inhibits neuronal process elongation in the N1E-115 cell line, a model line undergoing neuronal differentiation. This inhibitory phenotype was accompanied by changes in marker protein expression. Of note, CHMP2B with the T104N mutation, but not the wild-type form, was preferentially accumulated in the Golgi body. Of the four major Golgi stress signaling pathways currently known, the pathway through Arf4, the small GTPase, was specifically upregulated in cells expressing CHMP2B with the T104N mutation. Conversely, knockdown of Arf4 with the cognate small interfering (si)RNA recovered the neuronal process elongation inhibited by the T104N mutation. These results suggest that the T104N mutation of CHMP2B inhibits morphological differentiation by triggering Golgi stress signaling, revealing a possible therapeutic molecular target for recovering potential molecular and cellular phenotypes underlying FTD/ALS7. MDPI 2023-08-11 /pmc/articles/PMC10443297/ /pubmed/37606396 http://dx.doi.org/10.3390/neurolint15030063 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Shirai, Remina
Cho, Mizuka
Isogai, Mikinori
Fukatsu, Shoya
Okabe, Miyu
Okawa, Maho
Miyamoto, Yuki
Torii, Tomohiro
Yamauchi, Junji
FTD/ALS Type 7-Associated Thr104Asn Mutation of CHMP2B Blunts Neuronal Process Elongation, and Is Recovered by Knockdown of Arf4, the Golgi Stress Regulator
title FTD/ALS Type 7-Associated Thr104Asn Mutation of CHMP2B Blunts Neuronal Process Elongation, and Is Recovered by Knockdown of Arf4, the Golgi Stress Regulator
title_full FTD/ALS Type 7-Associated Thr104Asn Mutation of CHMP2B Blunts Neuronal Process Elongation, and Is Recovered by Knockdown of Arf4, the Golgi Stress Regulator
title_fullStr FTD/ALS Type 7-Associated Thr104Asn Mutation of CHMP2B Blunts Neuronal Process Elongation, and Is Recovered by Knockdown of Arf4, the Golgi Stress Regulator
title_full_unstemmed FTD/ALS Type 7-Associated Thr104Asn Mutation of CHMP2B Blunts Neuronal Process Elongation, and Is Recovered by Knockdown of Arf4, the Golgi Stress Regulator
title_short FTD/ALS Type 7-Associated Thr104Asn Mutation of CHMP2B Blunts Neuronal Process Elongation, and Is Recovered by Knockdown of Arf4, the Golgi Stress Regulator
title_sort ftd/als type 7-associated thr104asn mutation of chmp2b blunts neuronal process elongation, and is recovered by knockdown of arf4, the golgi stress regulator
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443297/
https://www.ncbi.nlm.nih.gov/pubmed/37606396
http://dx.doi.org/10.3390/neurolint15030063
work_keys_str_mv AT shirairemina ftdalstype7associatedthr104asnmutationofchmp2bbluntsneuronalprocesselongationandisrecoveredbyknockdownofarf4thegolgistressregulator
AT chomizuka ftdalstype7associatedthr104asnmutationofchmp2bbluntsneuronalprocesselongationandisrecoveredbyknockdownofarf4thegolgistressregulator
AT isogaimikinori ftdalstype7associatedthr104asnmutationofchmp2bbluntsneuronalprocesselongationandisrecoveredbyknockdownofarf4thegolgistressregulator
AT fukatsushoya ftdalstype7associatedthr104asnmutationofchmp2bbluntsneuronalprocesselongationandisrecoveredbyknockdownofarf4thegolgistressregulator
AT okabemiyu ftdalstype7associatedthr104asnmutationofchmp2bbluntsneuronalprocesselongationandisrecoveredbyknockdownofarf4thegolgistressregulator
AT okawamaho ftdalstype7associatedthr104asnmutationofchmp2bbluntsneuronalprocesselongationandisrecoveredbyknockdownofarf4thegolgistressregulator
AT miyamotoyuki ftdalstype7associatedthr104asnmutationofchmp2bbluntsneuronalprocesselongationandisrecoveredbyknockdownofarf4thegolgistressregulator
AT toriitomohiro ftdalstype7associatedthr104asnmutationofchmp2bbluntsneuronalprocesselongationandisrecoveredbyknockdownofarf4thegolgistressregulator
AT yamauchijunji ftdalstype7associatedthr104asnmutationofchmp2bbluntsneuronalprocesselongationandisrecoveredbyknockdownofarf4thegolgistressregulator